|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 405/06 | |
| C07D 239/42 |
| (11) | Patento numeris | 1682536 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04768997.1 |
| Europos patento paraiškos padavimo data | 2004-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-02-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2004/004481 |
| Data | 2004-10-22 |
| (87) | Numeris | WO 2005/042522 |
| Data | 2005-05-12 |
| (30) | Numeris | Data | Šalis |
| 0324791 | 2003-10-24 | GB |
| (72) |
OKADA, Tetsuo, Shionogi & Company Limited, JP
HORBURY, John, AstraZeneca, GB
LAFFAN, David Dermot Patrick, AstraZeneca, GB
|
| (73) |
AstraZeneca UK Limited,
2 Kingdom Street, London W2 6BD,
GB
SHIONOGI & CO., LTD., 1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, JP |
| (54) | PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO] PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF |
| PROCESS FOR THE MANUFACTURE OF THE CALCIUM SALT OF ROSUVASTATIN (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO] PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATES THEREOF |